Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ontario Molecular Diagnostics (OMD) is a private clinical laboratory headquartered in Richmond Hill, Ontario, specializing in high-complexity molecular testing. The company provides a wide range of diagnostic services, including somatic and hereditary cancer testing, infectious disease screening, and pharmacogenetics. Utilizing state-of-the-art technologies such as Next-Generation Sequencing (NGS) and real-time PCR, OMD delivers precise genomic data to facilitate personalized treatment plans. Their oncology portfolio includes comprehensive panels for lung, colorectal, and breast cancers, identifying actionable mutations for targeted therapies. OMD is licensed by the Ontario Ministry of Health and maintains rigorous quality standards to support clinical decision-making and patient care across Canada.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ontario Molecular Diagnostics.